Newly developed switch activates genes thousands of times better than nature – Phys.Org
Phys.Org |
Newly developed switch activates genes thousands of times better than nature
Phys.Org “For anything to happen in biology, the ‘light’ has to be turn on,” said Lucks, a member of Northwestern’s Center for Synthetic Biology. “We’re always interested in turning things on, so we found a way to engineer some really good light switches … |
Phys.Org |
Newly developed switch activates genes thousands of times better than nature
Phys.Org “For anything to happen in biology, the ‘light’ has to be turn on,” said Lucks, a member of Northwestern’s Center for Synthetic Biology. “We’re always interested in turning things on, so we found a way to engineer some really good light switches … |
Business Wire (press release) |
The New York Stem Cell Foundation Honors “Stem Cell Heroes” Andreas C. Dracopoulos; Roy Geronemus, MD, and …
Business Wire (press release) NEW YORK–(BUSINESS WIRE)–The New York Stem Cell Foundation (NYSCF) hosted its 12th annual Science Fair and Gala at Jazz at Lincoln Center’s Frederick P. Rose Hall. At this year’s Gala, Susan L. Solomon, CEO and Co-Founder of NYSCF, proudly … |
Fall River Herald News |
Learn more about immunotherapy treatments
Fall River Herald News Dr. John Yang: For years, physicians and patients have dreamed of allowing the body’s immune system to fight a patient’s cancer, in hopes that this approach would prove more effective and have fewer side effects than traditional chemotherapy. |
Fall River Herald News |
Learn more about immunotherapy treatments
Fall River Herald News Dr. John Yang: For years, physicians and patients have dreamed of allowing the body’s immune system to fight a patient’s cancer, in hopes that this approach would prove more effective and have fewer side effects than traditional chemotherapy. |
Gizmodo |
The FDA Just Approved Another Promising Immunotherapy for Cancer
Gizmodo The FDA’s approval of Yescarta, manufactured by Kite Pharma, comes just a few months after its first approval—an indication of just how quickly the field of immunotherapy is moving. Several other companies also have CAR-T therapies in the works. Cutting-edge immunotherapy treatment approved for another deadly cancerWashington Post Gilead cancer immunotherapy wins US approval with $373000 priceNasdaq F.D.A. Approves Second Gene-Altering Treatment for Cancer – The …New York Times PR Newswire (press release) –Markets Insider –The San Diego Union-Tribune –FDA.gov all 106 news articles » |